{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T12:50:16Z","timestamp":1753275016034,"version":"3.40.3"},"reference-count":21,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gynecologic Oncology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.ygyno.2012.09.019","type":"journal-article","created":{"date-parts":[[2012,9,25]],"date-time":"2012-09-25T06:38:26Z","timestamp":1348555106000},"page":"28-33","source":"Crossref","is-referenced-by-count":11,"title":["Parenchymal splenic metastasis is an independent negative predictor of overall survival in advanced ovarian, fallopian tube, and primary peritoneal cancer"],"prefix":"10.1016","volume":"128","author":[{"given":"Edward J.","family":"Tanner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kara C.","family":"Long","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jill B.","family":"Feffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Mario M.","family":"Leitao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadeem R.","family":"Abu-Rustum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard R.","family":"Barakat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dennis S.","family":"Chi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ginger J.","family":"Gardner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ygyno.2012.09.019_bb0005","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.ygyno.2006.06.028","article-title":"The addition of extensive upper abdominal surgery to achieve optimal cytoreduction improves survival in patients with stages IIIC-IV epithelial ovarian cancer","volume":"103","author":"Eisenhauer","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0010","first-page":"CD007565","article-title":"Optimal primary surgical treatment for advanced epithelial ovarian cancer","author":"Elattar","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0015","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/gyno.2000.5800","article-title":"Splenectomy and surgical cytoreduction for ovarian cancer","volume":"77","author":"Chen","year":"2000","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1048-891X.2004.014940.x","article-title":"The influence of splenic metastases on survival in FIGO stage IIIC epithelial ovarian cancer","volume":"14","author":"Ayhan","year":"2004","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0025","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1245\/s10434-011-1661-z","article-title":"Prognostic significance of splenectomy as part of initial cytoreductive surgery in ovarian cancer","volume":"18","author":"McCann","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0030","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s00404-004-0612-3","article-title":"Splenectomy in cytoreductive surgery for advanced ovarian cancer","volume":"271","author":"Bilgin","year":"2005","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0035","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1006\/gyno.1995.1218","article-title":"Splenectomy as part of cytoreductive surgery for ovarian carcinoma","volume":"58","author":"Nicklin","year":"1995","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0040","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1006\/gyno.1998.5145","article-title":"Survival impact of surgical cytoreduction in stage IV epithelial ovarian cancer","volume":"72","author":"Bristow","year":"1999","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0045","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1200\/JCO.2007.13.1953","article-title":"Tumor residual after surgical cytoreduction in prediction of clinical outcome in stage IV epithelial ovarian cancer: a Gynecologic Oncology Group Study","volume":"26","author":"Winter","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0050","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ygyno.2008.09.046","article-title":"The clinical significance of hepatic parenchymal metastasis in patients with primary epithelial ovarian cancer","volume":"112","author":"Lim","year":"2009","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0055","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.jamcollsurg.2009.01.006","article-title":"Quality improvement in the surgical approach to advanced ovarian cancer: the Mayo Clinic experience","volume":"208","author":"Aletti","year":"2009","journal-title":"J Am Coll Surg"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0060","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ygyno.2009.11.022","article-title":"The effect of primary cytoreduction on outcomes of patients with FIGO stage IIIC ovarian cancer stratified by the initial tumor burden in the upper abdomen cephalad to the greater omentum","volume":"116","author":"Zivanovic","year":"2010","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0065","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.ygyno.2005.08.036","article-title":"Splenectomy in the context of primary cytoreductive operations for advanced epithelial ovarian cancer","volume":"100","author":"Eisenkop","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0070","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ygyno.2006.03.028","article-title":"Splenectomy as part of cytoreductive surgery in ovarian cancer","volume":"102","author":"Magtibay","year":"2006","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0075","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2354.2010.01224.x","article-title":"Splenectomy and surgical cytoreduction in epithelial ovarian cancer: a review","volume":"20","author":"Hanprasertpong","year":"2011","journal-title":"Eur J Cancer Care"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0080","first-page":"269","article-title":"Safety and efficacy of a splenectomy during debulking surgery for Mullerian carcinoma","volume":"32","author":"Uehara","year":"2011","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0085","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/IGC.0b013e3181e4a6d8","article-title":"Correlation between macroscopic and microscopic diseases on splenectomies performed in the surgical management of ovarian cancer","volume":"20","author":"Uzan","year":"2010","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0090","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1097\/IGC.0b013e318227c971","article-title":"Current clinical practice in cytoreductive surgery for advanced ovarian cancer: a European survey","volume":"21","author":"Cibula","year":"2011","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0095","first-page":"36","article-title":"Splenic metastases in gynaecologic cancer: clinical considerations, US, and CT diagnostic results","volume":"106","author":"La Fianza","year":"2003","journal-title":"Radiol Med"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0100","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0009-9260(98)80269-9","article-title":"CT appearances and prognostic significance of splenic metastasis in ovarian cancer","volume":"53","author":"Spencer","year":"1998","journal-title":"Clin Radiol"},{"key":"10.1016\/j.ygyno.2012.09.019_bb0105","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/0090-8258(89)90068-1","article-title":"Splenectomy during primary maximal cytoreductive surgery for epithelial ovarian cancer","volume":"35","author":"Sonnendecker","year":"1989","journal-title":"Gynecol Oncol"}],"container-title":["Gynecologic Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812007755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090825812007755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T10:52:27Z","timestamp":1744195947000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090825812007755"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":21,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["S0090825812007755"],"URL":"https:\/\/doi.org\/10.1016\/j.ygyno.2012.09.019","relation":{},"ISSN":["0090-8258"],"issn-type":[{"type":"print","value":"0090-8258"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}